O’Melveny represented TYK Medicines in the transaction. TYK Medicines, Inc. (2410.HK) executed its initial public offering and listing on the Main Board of the Hong Kong...
TYK Medicines’ US$74 Million Hong Kong IPO
RemeGen’s A-share IPO and Listing on SSE STAR Market
O’Melveny represented RemeGen Co. on the deal. RemeGen Co., Ltd. (“RemeGen”) (9995.HK; 688331.SH) announced its A-share listing on the Sci-Tech Innovation Board of the Shanghai Stock...